Related Experiment Video
Updated: May 20, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
HPV and Cervical Cancer-Biology, Prevention, and Treatment Updates
Emilia Włoszek1, Kamila Krupa1, Eliza Skrok1
1Students' Scientific Organization of Cancer Cell Biology, Department of Oncology Propaedeutics, Medical University of Warsaw, 02-091 Warsaw, Poland.
Persistent human papillomavirus (HPV) infection causes cervical cancer. This review covers the latest advances in HPV vaccination, diagnostics, and treatments, emphasizing ongoing strategies for prevention and control.
Area of Science:
- Oncology
- Virology
- Public Health
Background:
- Persistent infection with specific human papillomavirus (HPV) genotypes is a primary cause of cervical cancer.
- Significant advancements in diagnostics and therapeutics have emerged since this link was established.
Purpose of the Study:
- To provide an updated overview of the biology, prevention, and treatment of HPV-related cervical cancer.
- To present current knowledge on HPV vaccinations, diagnostic tests, and therapies.
- To highlight emerging research and future directions in HPV-related cervical cancer management.
Main Methods:
- Review of current scientific literature and guidelines.
- Analysis of recent developments in HPV vaccination strategies, including WHO guidelines.
- Examination of novel diagnostic approaches, such as self-administered tests and cell-free DNA.
- Summary of therapeutic advancements, including therapeutic vaccines.
Main Results:
- The article details the current landscape of HPV vaccination, diagnostic tools, and treatment modalities.
- It incorporates the latest World Health Organization (WHO) guidelines on HPV vaccination and anticipates future changes.
- Emerging technologies like self-administered HPV tests, therapeutic vaccines, and circulating cell-free DNA for diagnosis are discussed.
Conclusions:
- Vaccination and regular screening remain the foundational strategies for combating HPV-related cervical cancer.
- Promising new diagnostic and therapeutic methods are under development, offering potential improvements in early detection and treatment.
- Continued research into areas like self-testing and novel vaccines is crucial for future progress.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Preventive Healthcare Services
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...